Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells
(Q28201813)
scientific article (publication date: 15 June 2001)
scientific article (publication date: 15 June 2001)
Language:
Current Data About
Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells
| (P31) |
(Q13442814)
|
||||||||||
| (P50) |
(Q6279267)
|
||||||||||
| (P304) |
4744-9
|
||||||||||
| (P407) |
(Q1860)
|
||||||||||
| (P433) |
12
|
||||||||||
| (P478) |
61
|
||||||||||
| (P577) |
Friday, June 15, 2001
|
||||||||||
| (P921) |
(Q79460)
(Q128581)
(Q412616)
(Q422248)
|
||||||||||
| (P1433) |
(Q326097)
|
||||||||||
| (P1476) |
"Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells" (language: en)
|
||||||||||
| (P2093) |
M A Molina
J Codony-Servat
J Albanell
F Rojo
J Arribas
|